Found 22 hits in this display Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 51 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
EUROSCREEN SA
US Patent
| Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... |
US Patent US9422299 (2016)
BindingDB Entry DOI: 10.7270/Q2GM866C |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2348QHC |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | 51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2348QHC |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA
US Patent
| Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... |
US Patent US10836768 (2020)
BindingDB Entry DOI: 10.7270/Q2Z03C74 |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 51 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals
| Assay Description Human NK-3: The ability of compounds of the invention to inhibit the binding of the NK-3 receptor selective antagonist 3H-SB222200 was assessed by an... |
Bioorg Med Chem 17: 3934-58 (2009)
BindingDB Entry DOI: 10.7270/Q2SN0C9W |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| 51 | n/a | n/a | n/a | n/a | n/a | n/a | 7.4 | n/a |
OGEDA SA
US Patent
| Assay Description The affinity of compounds of the invention for the human NK-3 receptor was determined by measuring the ability of compounds of the invention to compe... |
US Patent US10030025 (2018)
BindingDB Entry DOI: 10.7270/Q2B56MSG |
More data for this Ligand-Target Pair | |
Substance-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA
US Patent
| Assay Description The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra... |
US Patent US10836768 (2020)
BindingDB Entry DOI: 10.7270/Q2Z03C74 |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | >-25.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
OGEDA SA
US Patent
| Assay Description The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra... |
US Patent US10030025 (2018)
BindingDB Entry DOI: 10.7270/Q2B56MSG |
More data for this Ligand-Target Pair | |
Substance-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2348QHC |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | >-25.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
EUROSCREEN SA
US Patent
| Assay Description The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra... |
US Patent US9422299 (2016)
BindingDB Entry DOI: 10.7270/Q2GM866C |
More data for this Ligand-Target Pair | |
Substance-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | >-25.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
EUROSCREEN SA
US Patent
| Assay Description The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra... |
US Patent US9422299 (2016)
BindingDB Entry DOI: 10.7270/Q2GM866C |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA
US Patent
| Assay Description The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 receptor. Membra... |
US Patent US10836768 (2020)
BindingDB Entry DOI: 10.7270/Q2Z03C74 |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| | >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2348QHC |
More data for this Ligand-Target Pair | |
Substance-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | >-25.8 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
OGEDA SA
US Patent
| Assay Description The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 receptor. Membra... |
US Patent US10030025 (2018)
BindingDB Entry DOI: 10.7270/Q2B56MSG |
More data for this Ligand-Target Pair | |
Substance-P receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals
| Assay Description Human NK-1: The affinity of compounds of the invention for the NK-1 receptor was evaluated in CHO recombinant cells which express the human NK-1 rece... |
Bioorg Med Chem 17: 3934-58 (2009)
BindingDB Entry DOI: 10.7270/Q2SN0C9W |
More data for this Ligand-Target Pair | |
Substance-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| >3.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals
| Assay Description Human NK-2 The affinity of compounds of the invention for the NK-2 receptor was evaluated in CHO recombinant cells which express the human NK-2 recep... |
Bioorg Med Chem 17: 3934-58 (2009)
BindingDB Entry DOI: 10.7270/Q2SN0C9W |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
OGEDA SA
US Patent
| Assay Description Changes in intracellular calcium levels are a recognized indicator of G protein-coupled receptor activity. The efficacy of compounds of the invention... |
US Patent US10030025 (2018)
BindingDB Entry DOI: 10.7270/Q2B56MSG |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA
US Patent
| Assay Description Changes in intracellular calcium levels are a recognized indicator of G protein-coupled receptor activity. The efficacy of compounds of the invention... |
US Patent US10836768 (2020)
BindingDB Entry DOI: 10.7270/Q2Z03C74 |
More data for this Ligand-Target Pair | |
Neuromedin-K receptor
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 50 | n/a | n/a | n/a | n/a | n/a | n/a |
EUROSCREEN SA
US Patent
| Assay Description Chinese Hamster Ovary recombinant cells expressing the human NK-3 receptor and a construct that encodes the photoprotein apoaequorin were used for th... |
US Patent US9422299 (2016)
BindingDB Entry DOI: 10.7270/Q2GM866C |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
EUROSCREEN SA
US Patent
| Assay Description The hERG inhibition study aims at quantifying the in vitro effects of compounds of the invention on the potassium-selective IKr current generated in ... |
US Patent US9422299 (2016)
BindingDB Entry DOI: 10.7270/Q2GM866C |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Ogeda SA
US Patent
| Assay Description The human ether-a-go-go related gene (hERG) encodes the inward rectifying voltage gated potassium channel in the heart (Igr) which is involved in car... |
US Patent US10836768 (2020)
BindingDB Entry DOI: 10.7270/Q2Z03C74 |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM242753
(US10030025, Compound 17 | US10836768, Cpd no 17 | ...)Show SMILES C[C@H]1N(CCn2c1nnc2-c1nc(C)ns1)C(=O)c1cc(F)cc(F)c1 |r| Show InChI InChI=1S/C16H14F2N6OS/c1-8-13-20-21-14(15-19-9(2)22-26-15)24(13)4-3-23(8)16(25)10-5-11(17)7-12(18)6-10/h5-8H,3-4H2,1-2H3/t8-/m1/s1 | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 4.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
OGEDA SA
US Patent
| Assay Description The human ether-a-go-go related gene (hERG) encodes the inward rectifying voltage gated potassium channel in the heart (IKr) which is involved in car... |
US Patent US10030025 (2018)
BindingDB Entry DOI: 10.7270/Q2B56MSG |
More data for this Ligand-Target Pair | |